Kuala Lumpur - Delayed Quote MYR

Hextar Healthcare Berhad (7803.KL)

0.2050 +0.0050 (+2.50%)
At close: 4:55 PM GMT+8
Key Events
Loading Chart for 7803.KL
DELL
  • Previous Close 0.2000
  • Open 0.2050
  • Bid 0.2000 x --
  • Ask 0.2050 x --
  • Day's Range 0.2000 - 0.2050
  • 52 Week Range 0.1950 - 0.3500
  • Volume 476,500
  • Avg. Volume 1,067,596
  • Market Cap (intraday) 205.394M
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date Feb 26, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jan 2, 2020
  • 1y Target Est --

Hextar Healthcare Berhad, an investment holding company, manufactures, trades, and sells In-Vitro Diagnostic (IVD) medical devices in Malaysia and Europe. It operates through Gloves Operation and Medical Devices Operation segments. The company offers natural rubber, synthetic rubber, and nitrile disposable gloves for household, industrial, and professional applications. It is also involved in the trading and sale of gloves, household and kitchen items, and personal protective products, as well as invests in properties. The company was formerly known as Rubberex Corporation (M) Berhad. The company was founded in 1987 and is headquartered in Ipoh, Malaysia.

www.rubberex.com.my

--

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 7803.KL

Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

7803.KL
29.31%
FTSE Bursa Malaysia KLCI
8.28%

1-Year Return

7803.KL
31.67%
FTSE Bursa Malaysia KLCI
10.52%

3-Year Return

7803.KL
85.36%
FTSE Bursa Malaysia KLCI
2.07%

5-Year Return

7803.KL
39.03%
FTSE Bursa Malaysia KLCI
3.70%

Compare To: 7803.KL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7803.KL

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    200.38M

  • Enterprise Value

    166.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.23

  • Price/Book (mrq)

    0.34

  • Enterprise Value/Revenue

    1.03

  • Enterprise Value/EBITDA

    -2.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -42.63%

  • Return on Assets (ttm)

    -7.17%

  • Return on Equity (ttm)

    -11.55%

  • Revenue (ttm)

    155.09M

  • Net Income Avi to Common (ttm)

    -66.12M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.81M

  • Total Debt/Equity (mrq)

    1.07%

  • Levered Free Cash Flow (ttm)

    22.16M

Company Insights: 7803.KL

People Also Watch